Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages
Published version of a preprint
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Plasmodium vivax elimination is challenged by dormant liver stages (hypnozoites) that can reactivate months after initial infection resulting in relapses. Relapsing infections confound antimalarial clinical efficacy trials due to the inability to distinguish between recurrences arising from blood-stage treatment failure (recrudescence), reinfection or relapse. Genetic relatedness of paired parasite isolates, measured by identity-by-descent (IBD), can provide important information on whether individuals have had single or multiple mosquito inoculations, thus informing on recurrence origin. We developed a high-throughput amplicon sequencing assay comprising 93 multi-SNP (microhaplotype) markers to determine IBD between P. vivax clinical isolates. The assay was evaluated in 745 global infections, including 128 infection pairs from a randomized controlled trial (RCT) (ClinicalTrials.gov NCT01680406). Simulations demonstrate low error in pairwise IBD estimation at the panel (RMSE < 0.12) and IBD-based networks illustrate strong clustering by geography. IBD analysis in the RCT demonstrates a lower frequency of suspected relapses or recrudescence in patients treated with primaquine compared to those without primaquine; the impact is greater when paired with chloroquine than with artemether-lumefantrine. Our results demonstrate the potential to derive new information on P. vivax treatment and transmission using IBD generated by amplicon sequencing data that can be further improved with time-to-event models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has led to them being increasingly adopted by research teams and national malaria control programmes (NMCPs) [13,14,17].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [13]
In the citing paper
“Amplicon-based sequencing of 93 microhaplotype markers, using highly parallel sequencing platforms, offers a cost effective and logistically efficient means to capture IBD accurately [13][14][15][16].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [13]
In the citing paper
“Using microhaplotype sequencing and a probabilistic classification model (Pv3Rs) to assess relatedness relationships within participants enrolled in two clinical trials, we provide molecular evidence that, in the absence of radical cure, relapse, not reinfection, is the dominant driver of recurrent P. vivax in Ethiopia [11,13,19,30].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [13]
In the citing paper
“In the case of P. vivax, high-resolution molecular tools offer critical added value by improving classification of recurrent infections and supporting more accurate estimates of treatment efficacy in radical cure clinical trials [29, 30].”
From Building the toolkit to address malaria resurgence and radical cure of vivax malaria in Ethiopia: a meeting report (2026) · cites this paper as [30]
In the citing paper
“Microhaplotype genotyping of P. vivax cases has been successfully applied to cases from multiple radical cure trials in Ethiopia [12, 30].”
From Building the toolkit to address malaria resurgence and radical cure of vivax malaria in Ethiopia: a meeting report (2026) · cites this paper as [30]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dobosy, J. R., Rose, S. D., Beltz, K. R., Rupp, S. M., Powers, K. M., Behlke, M. A., & Walder, J. A. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-80 · Cited by 184 · cited 1×
“Allplotsweregeneratedusingdataonindependent infections with sample sizes shown within the plots. the need for pre-ampli fi cation steps relative to standard AmpSeq as it minimizes spurious primer-primer interactions and off-target ampli fi cation 27 .”
Popovici, J., Pierce-Friedrich, L., Kim, S., Bin, S., Run, V., Lek, D., Hee, K. H. D., Lee Soon-U, L., Cannon, M. V., Serre, D., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy484 · Cited by 59
Siegel, S. V., Trimarsanto, H., Amato, R., Murie, K., Taylor, A. R., Sutanto, E., Kleinecke, M., Whitton, G., Watson, J. A., Imwong, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51015-3 · Cited by 30
Self-citation
Research works printed but not linked: 63
- Auburn, S., Cheng, Q., Marfurt, J. & Price, R. N. The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools. PLoS Med. 18, e1003560 (2021). · DOI · Paper page
- Douglas, N. M. et al. Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med. 12, 217 (2014). · DOI
- Commons, R. J. et al. Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis. Lancet Child Adolesc. Health 8, 798–808 (2024). · doi:10.1016/s2352-4642(24)00210-4
- Verma, R. et al. Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis. BMJ Glob. Health 8, https://doi.org/10.1136/bmjgh-2023-012675 (2023). · DOI
- Mehdipour, P. et al. Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. Malar. J. 22, 306 (2023). · DOI
- Rajasekhar, M. et al. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. Lancet Infect. Dis. 24, 184–195 (2024). · DOI · Paper page
- Commons, R. J. et al. Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis. Lancet Infect. Dis. 24, 172–183 (2024). · DOI · Paper page
- White, N. J. & Imwong, M. Relapse. Adv. Parasitol. 80, 113–150 (2012). · DOI · Paper page
- Snounou, G. & Beck, H. P. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today 14, 462–467 (1998). · DOI · Paper page
- Imwong, M. et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195, 927–933 (2007). · DOI · Paper page
- Chen, N., Auliff, A., Rieckmann, K., Gatton, M. & Cheng, Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195, 934–941 (2007). · DOI · Paper page
- Abdullah, N. R. et al. Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia. PloS one 8, e82553 (2013). · DOI
- Bright, A. T. et al. A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings. PLoS Neglect. Tropic. Dis. 8, e2882 (2014). · DOI · Paper page
- Popovici, J. et al. Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia. mBio 9, https://doi.org/10.1128/mBio.01888-17 (2018). · DOI
- Ruybal-Pesantez, S. et al. Molecular markers for malaria genetic epidemiology: progress and pitfalls. Trends Parasitol. 40, 147–163 (2024). · DOI · Paper page
- Abreha, T. et al. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial. PLoS Med. 14, e1002299 (2017). · DOI · Paper page
- Battle, K. E. et al. Geographical variation in Plasmodium vivax relapse. Malar. J. 13, 144 (2014). · DOI · Paper page
- Jacob, C. G. et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. eLife 10, https://doi.org/10.7554/eLife.62997 (2021). · DOI · Paper page
- Price, R. N., Auburn, S., Marfurt, J. & Cheng, Q. Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax. Trends Parasitol. 28, 522–529 (2012). · DOI
- Suwanarusk, R. et al. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PloS one 2, e1089 (2007). · DOI · Paper page
- Groves, E. S. et al. Parasitaemia and fever in uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. PLoS Neglect. Tropic. Dis. 19, e0012951 (2025). · DOI
- Cowell, A. N. et al. Selective whole-genome amplification is a robust method that enables scalable whole-genome sequencing of Plasmodium vivax from unprocessed clinical samples. mBio 8, https://doi.org/10.1128/mBio.02257-16 (2017). · DOI
- Arneson, N., Hughes, S., Houlston, R. & Done, S. Whole-genome amplification by improved primer extension preamplification PCR (I-PEP-PCR). CSH Protoc. 2008, pdb prot4921 (2008).
- Baniecki, M. L. et al. Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections. PLoS Neglect. Tropic. Dis. 9, e0003539 (2015). · DOI · Paper page
- Taylor, A. R., Jacob, P. E., Neafsey, D. E. & Buckee, C. O. Estimating relatedness between malaria parasites. Genetics 212, 1337–1351 (2019). · DOI · Paper page
- Taylor, A. R. et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat. Commun. 10, 5595 (2019). · DOI · Paper page
- Karunajeewa, H. A. et al. A trial of combination antimalarial therapies in children from Papua New Guinea. N. Engl. J. Med. 359, 2545–2557 (2008). · DOI · Paper page
- Baird, J. K. 8-aminoquinoline therapy for latent malaria. Clin. Microbiol. Rev. 32, https://doi.org/10.1128/CMR.00011-19 (2019). · DOI · Paper page
- Anstey, N. M. et al. The biology and pathogenesis of vivax malaria. Trends Parasitol. 40, 573–590 (2024). · DOI
- Trimarsanto, H. et al. A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria. Commun. Biol. 5, 1411 (2022). · DOI · Paper page
- Buyon, L. E., Elsworth, B. & Duraisingh, M. T. The molecular basis of antimalarial drug resistance in Plasmodium vivax. Int. J. Parasitol. Drugs Drug Resist. 16, 23–37 (2021). · DOI
- Ratcliff, A. et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. Soc. Tropic. Med. Hyg. 101, 351–359 (2007). · DOI · Paper page
- Pearson, R. D. et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat. Genet. 48, 959–964 (2016). · DOI · Paper page
- Assefa, M., Eshetu, T. & Biruksew, A. Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia. Malar. J. 14, 458 (2015). · DOI · Paper page
- Getachew, S. et al. Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia. Malar. J. 14, 525 (2015). · DOI · Paper page
- Thuan, P. D. et al. A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam. Am. J. Tropic. Med. Hyg. 94, 879–885 (2016). · doi:10.4269/ajtmh.15-0740
- Phong, N. C. et al. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam. Malar. J. 18, 10 (2019). · DOI
- Kolaczinski, K., Durrani, N., Rahim, S. & Rowland, M. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan. Trans. R. Soc. Tropic. Med. Hyg. 101, 1081–1087 (2007). · DOI
- Leslie, T. et al. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. JAMA 297, 2201–2209 (2007). · doi:10.1001/jama.297.20.2201
- Awab, G. R. et al. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial. Malar. J. 9, 105 (2010). · DOI
- Sutanto, I. et al. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia. Malar. J. 9, 52 (2010). · DOI
- Fryauff, D. J. et al. The drug sensitivity and transmission dynamics of human malaria on Nias Island, North Sumatra, Indonesia. Ann. Trop. Med Parasitol. 96, 447–462 (2002). · DOI
- Ley, B. et al. G6PD deficiency and antimalarial efficacy for uncomplicated Malaria in Bangladesh: A Prospective Observational Study. PloS one 11, e0154015 (2016). · DOI
- Castillo, C. M., Osorio, L. E. & Palma, G. I. Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia. Mem. do Inst. Oswaldo Cruz 97, 559–562 (2002). · DOI
- Mesa-Echeverry, E., Niebles-Bolivar, M. & Tobon-Castano, A. Chloroquine-primaquine therapeutic efficacy, safety, and plasma levels in patients with uncomplicated Plasmodium vivax Malaria in a Colombian Pacific Region. Am. J. Tropic. Med. Hyg. 100, 72–77 (2019). · DOI · Paper page
- Perez, M. A. et al. Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Cordoba, Colombia, 2006]. Biomedica 28, 148–159 (2008). · DOI
- Alvarez, G. et al. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Am. J. Tropic. Med. Hyg. 75, 605–609 (2006). · DOI
- Higgins, M. et al. New reference genomes to distinguish the sympatric malaria parasites, Plasmodium ovale curtisi and Plasmodium ovale wallikeri. Sci. Rep. 14, 3843 (2024). · DOI
- Popkin-Hall, Z. R. et al. High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes. Nat. Commun. 15, 10219 (2024). · DOI · Paper page
- Fola, A. A. et al. SNP barcodes provide higher resolution than microsatellite markers to measure Plasmodium vivax population genetics. Malar. J. 19, 375 (2020). · DOI
- Kattenberg, J. H. et al. Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales. Front. Cell. Infect. Microbiol. 11, https://doi.org/10.3389/fcimb.2022.953187 (2022). · DOI
- MalariaGen et al. An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples. Wellcome Open Res. 7, 136 (2022). · DOI · Paper page
- Taylor, W. R. J. et al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet 394, 929–938 (2019). · DOI · Paper page
- Grigg, M. J. et al. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial. Lancet Infect. Dis. 16, 180–188 (2016). · DOI
- Gruenberg, M. et al. Plasmodium vivax molecular diagnostics in community surveys: pitfalls and solutions. Malar. J. 17, 55 (2018). · DOI
- Auburn, S. et al. A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes. Wellcome Open Res. 1, 4 (2016). · DOI
- Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009). · DOI · Paper page
- LaVerriere, E. et al. Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: a malaria case study. Mol. Ecol. Resour. 22, 2285–2303 (2022). · DOI
- Murphy, M. & Greenhouse, B. MOIRE: A software package for the estimation of allele frequencies and effective multiplicity of infection from polyallelic data. Bioinformatics, 40, btae619 (2024). · DOI
- Auburn, S. et al. Characterization of within-host Plasmodium falciparum diversity using next-generation sequence data. PloS one 7, e32891 (2012). · DOI · Paper page
- Gerlovina, I., Gerlovin, B., Rodriguez-Barraquer, I. & Greenhouse, B. Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections. Genetics 222, https://doi.org/10.1093/genetics/iyac126 (2022). · DOI · Paper page
- Paradis, E., Claude, J. & Strimmer, K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20, 289–290 (2004). · DOI · Paper page
- Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797 (2004). · DOI · Paper page
Cited by
Degaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Self-citationOsborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Self-citation
Metadata
- Authors
- Kleinecke, M., Sutanto, E., Rumaseb, A., Hoon, K. S., Trimarsanto, H., Osborne, A., Manrique, P., Peters, T., Hawkes, D., Benavente, E. D., Whitton, G., Siegel, S. V., Pearson, R. D., Amato, R., Rai, A., Nhien, N. T. T., Nguyen, H. C., Assefa, A., Degaga, T. S., Abate, D. T., Rahim, A. G., Pasaribu, A. P., Sutanto, I., Alam, M. S., Pava, Z., Lopera-Mesa, T., Echeverry, D., William, T., Anstey, N. M., Grigg, M. J., Day, N. P., White, N. J., Kwiatkowski, D. P., Taylor, A. R., Noviyanti, R., Neafsey, D., Price, R. N., & Auburn, S.
- Venue
- Nature Communications
- Published
- 2025-08-05
- Volume
- 16
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 19
- References
- 3
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Bill and Melinda Gates Foundation (INV-043618)
- Department of Health | National Health and Medical Research Council (APP2001083)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages. https://app.cochat.ai/papers/10.1038/s41467-025-62357-x
- The paper
- Kleinecke, M., Sutanto, E., Rumaseb, A., Hoon, K. S., Trimarsanto, H., Osborne, A., Manrique, P., Peters, T., Hawkes, D., Benavente, E. D., Whitton, G., Siegel, S. V., Pearson, R. D., Amato, R., Rai, A., Nhien, N. T. T., Nguyen, H. C., Assefa, A., Degaga, T. S., . . . Auburn, S. (2025). Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages. Nature Communications. https://doi.org/10.1038/s41467-025-62357-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.